Kidney Cancer Trial, Recruiting NCT01109394 Sponsor: National Cancer Institute (NCI) Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT01109394
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with any type of tumor, cancer, pre-cancerous condition, or are suspected of having a hereditary condition that may lead to cancer (this applies to any age)
  • You are a blood relative of someone who has been diagnosed with a tumor, cancer, pre-cancerous condition, or a suspected hereditary cancer-related condition (this applies to any age)
  • You are a healthy volunteer with no personal history of cancer and no family member currently being treated for cancer, and you are having surgery, receiving treatment, or attending a routine health visit
  • Samples can be collected from you with very little extra risk, as part of tests or procedures you are already having for your regular care
  • You have human samples or data that were collected as part of a previous research study that has now ended
  • You (or your parent, legal guardian, or authorized representative if you are under 18 or unable to consent yourself) are able to understand and sign the required consent form allowing your samples to be used for genetic research

For people joining the interview portion of the study:

  • You are a parent or caregiver of a child or adult patient who is currently being treated, or has previously been treated, for any type of childhood cancer
  • You are able to give your own consent and sign the consent form
  • You are able to understand and communicate in English

Who may not be able to join:

  • There are no listed exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rosandra N Kaplan, M.D., National Cancer Institute (NCI)

Phone: (240) 760-6189

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 April 2010

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

tissue analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov